Mizuho analyst Irina Rivkind Koffler weighed in today on Mallinckrodt PLC (NYSE:MNK), after the pharmaceutical company entered into a purchase agreement with The Medicines Company to …
Analysts from Mizuho Securities and Cannacord weigh in on biopharm companies Allergan PLC (NYSE:AGN) and Mallinckrodt PLC (NYSE:MNK) following Pfizer-Allergan merger deal and …
In a research report issued today, Oppenheimer analyst Akiva Felt reiterated an Outperform rating on Mallinckrodt (NYSE:MNK) with a $111 price target, which …
In a research note released this morning, Deutsche Bank analyst Gregg Gilbert reaffirmed a Buy rating on Mallinckrodt (NYSE:MNK) with a $102 price …
